🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with glp-1 hepatoprotection? Page 5

Has anyone dealt with glp-1 hepatoprotection?

GenomicsKate Fri, Jul 11, 2025 at 12:32 PM 33 replies 1,678 viewsPage 5 of 7
B12Beth
Member
289
890
Oct 2024
Maryland
Jul 17, 2025 at 2:38 PM#21
wendy_avl said:
If you are going to change something, change one thing and give it long enough to express itself.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

34 7GraceAZ_72, carl_compliance, DanielChem_CHI and 31 others
Reply Quote Save Share Report
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Jul 19, 2025 at 7:46 AM#22
wendy_avl said:
If you are going to change something, change one thing and give it long enough to express itself.

This is exactly what I could not find anywhere else. Printing the relevant bit and taking it with me.

35 8FranDenver, Dr.BariatricHTX, LindaRN_retired and 32 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Jul 21, 2025 at 12:53 AM#23

Adding the clinical framing, because it changes how the question reads. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

36 9MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 33 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Jul 22, 2025 at 5:59 PM#24
KevinCompounds said:
Start from the measurement rather than the conclusion.

Same experience, arrived at from the opposite direction.

37 10LondonLisa, mike_nyc, VendorMark and 34 others
Reply Quote Save Share Report
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Jul 24, 2025 at 11:04 AM#25
KevinCompounds said:
Start from the measurement rather than the conclusion.

Adding the part of the answer the thread has not reached. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

38 11AttorneyGrant, DebRD_ATL, KristenIndy and 35 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register